NASDAQ: SNY
Sanofi Earnings & Revenue

SNY past earnings growth

How has SNY's earnings growth performed historically?
Company
-35.07%
Industry
10.68%
Market
82.89%
SNY's earnings have grown slower (-7.68% per year) than the US Drug Manufacturers - General industry average (8.89%)
Performance
SNY's earnings have grown slower (-7.68% per year) than the US market average (77.34%)
Performance
SNY's earnings growth is slowing down - its growth over the last year (-35.07%) is below its 5-year compound annual rate (-7.68%)
Performance

SNY past revenue growth

How has SNY's revenue growth performed historically?
Company
5.48%
Industry
6.62%
Market
16.55%
SNY's revenue has grown slower (3.30% per year) than the US Drug Manufacturers - General industry average (4.07%)
Performance
SNY's revenue has grown slower (3.30% per year) than the US market average (15.67%)
Performance
SNY's revenue growth is accelerating - its growth over the last year (5.48%) is above its 5-year compound annual rate (3.30%)
Performance

SNY earnings and revenue history

Current Revenue
$37.6B
Current Earnings
$2.8B
Current Profit Margin
7.50%
SNY's has not demonstrated consistent long-term earnings growth over the past 10 years (-44.42%)
Performance

SNY Return on equity

Current Company
4.80%
Current Industry
36.30%
Current Market
14.90%
SNY's Return on Equity (4.80%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

SNY Return on assets

Current Company
2.50%
Current Industry
9.40%
Current Market
6.90%
SNY is generating lower Return on Assets (2.50%) than the US Drug Manufacturers - General industry average (8.27%)
Performance

SNY Return on capital employed

Current Company
3.67%
Current Industry
14.40%
SNY's ability to generate Return on Capital (3.67%) has decreased compared to 3 years ago (7.89%)
Performance

Sanofi Earnings & Revenue FAQ

As of Q4 2020, Sanofi's earnings has grown -35.07% year over year. This is 45.76 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 10.68%. Sanofi's earnings in the past year totalled $2.81 billion.
As of Q4 2020, Sanofi's revenue has grown 5.48% year over year. This is 1.14 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 6.62%. Sanofi's revenue in the past year totalled $37.63 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics